Dr. Gary Rankin receives alumni award from Ole Miss

Gary O. Rankin, Ph.D.Dr. Gary O. Rankin, professor and chair of the Department of Pharmacology, Physiology and Toxicology at the Joan C. Edwards School of Medicine, was recently honored by the Department of Medicinal Chemistry at the University of Mississippi School of Pharmacy with its Joseph Sam Distinguished Alumni Award.

Rankin, who graduated with his doctorate from “Ole Miss” in 1976, joined the Marshall University faculty in 1978 after completing postdoctoral work at the Medical College of Ohio, now the University of Toledo. Rankin serves as principal investigator for the National Institutes of Health-funded West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) program. He has authored or coauthored more than 100 peer-reviewed manuscripts, eight review articles, 13 book chapters and nearly 200 research presentations at local, regional, national and international meetings.

Rankin was honored in March during a ceremony in Oxford, Miss.

This article was published in this week’s edition of the We Are…Marshall newsletter. (http://www.marshall.edu/wamnewsletter/2013/04/16/dr-gary-rankin-receives-alumni-award-from-ole-miss/

Racine attends the Society of Toxicology General Meeting in San Antonio, Texas

by M. Allison Wolf

Chris Racine, Ph.D. student, on far leftBiomedical Sciences Ph.D. student Chris Racine recently presented his research at the Society of Toxicology (SOT) General Meeting in San Antonio, Texas. The study Chris presented at this meeting was entitled “Role of renal cytochrome p450 isozymes in the bioactivation of 3,5-dichloroaniline in vitro.” The long term goal of this project is “to determine the biotransformation of 3,5-dichloroaniline (3,5-DCA), mechanisms for bioactivation of 3,5-DCA to nephrotoxic species by the kidney, and if gender differences exist in the susceptibility of the kidney to the toxic effects of 3,5-DCA.”   

The SOT conference, which was held from March 10-14, is the largest toxicology meeting in the world and it brings together scientist in academia, government, and industry from various countries. Dr. Gary Rankin, Chris Racine’s Ph.D. advisor said that, “It is important for students to experience the scientific exchange that happens at a national research conference. There is no substitute for attending such a meeting in person. The meeting also gives the advisor the opportunity to introduce the students to other top scientists and students in their field, and the feedback received at a national presentation can be very helpful for the student’s research projects.”

Congratulations, Chris!

JCE School of Medicine Faculty Present Research at the National IDeA Meeting

Every two years the National IDeA Symposium of Biomedical Research Excellence (NISBRE) meeting is held in Washington D.C. to bring together faculty, fellows and students that participate in the National Institutes of Health’s Institutional Development Award (IDeA) programs. This year the NISBRE meeting was held June 25-27, 2012 at the Benja Lamyaithong Marshall INBRE studentOmni Shoreham Hotel and was attended by six faculty members from the Joan C. Edwards School of Medicine, Marshall University in the West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) program, three from West Virginia University and one each from Bluefield State College, Concord College, West Virginia State University, West Virginia Wesleyan College and the University of Charleston. Several of the Marshall University faculty presented research during the meeting including Drs. Monica Valentovic, Nalini Santanam Nalini Santanam, Ph.D./M.P.H.and Travis Salisbury from the Department of Pharmacology, Physiology and Toxicology and Dr. Donald Primerano from the Department of Biochemistry and Microbiology. Also presenting research was Andre Benja Lamyaithong, an undergraduate student at Wheeling Jesuit University, who has been conducting research on antidotes for acetaminophen overdose with Dr. Valentovic for two summers as part of the West Virginia INBRE summer research program. Other JCE School of Medicine faculty members attending the meeting were: Dr. Jim Denvir, Department of Biochemistry and Microbiology, who co-authored the work with Dr. Primerano; and Dr. Gary Rankin, Department of Pharmacology, Physiology and Toxicology, who is a member of the Executive Planning Committee for the NISBRE meeting. 

 

Monica Valentovic, Ph.D.Dr.Valentovic’s research on how a component of grapes and red wine (resveratrol) can reduce damage to the kidney caused by a commonly used drug (cisplatin) to treat cancer was presented in a regular research session and highlighted in a special session on clinical and translational research. In addition, Dr. Primerano’s research into the genetics of families with high blood cholesterol was highlighted in a special session on cardiovascular disease.

The IDeA program was started in 1993 to help increase the biomedical research competitiveness in states that receive only small amounts of research funding from the National Institutes of Health. The IDeA program is composed of two award programs, one (Centers Of Biomedical Research Excellence; COBRE) that is designed to create centers with a biomedical research focus at larger research schools and a second program (INBRE) designed to build the biomedical research infrastructure at smaller colleges and universities and provide biomedical research training primarily to undergraduate students.Travis Salisbury, Ph.D. Currently, 23 states and Puerto Rico are eligible to compete for COBRE or INBRE grants. Marshall University was awarded an INBRE grant as the lead institution in 2004 with West Virginia University serving as a partner lead institution.  Dr. Gary Rankin, Professor and Chair of the Department of Pharmacology, Physiology and Toxicology at Marshall University is the Principal Investigator for the WV-INBRE program.

Dr. Piyali Dasgupta awarded NIH grant for lung cancer research

Piyali Dagupta, Ph.D., and Monica Valentovic, Ph.D.HUNTINGTON, W.Va. – A Marshall University faculty member has been awarded a three-year, $426,000 grant by the National Institutes of Health (NIH) to further her lung cancer research.
 
Dr. Piyali Dasgupta, associate professor in the Department of Pharmacology, Physiology and Toxicology in the university’s Joan C. Edwards School of Medicine, will use the grant to continue her work to determine if the nutritional agent capsaicin—the active ingredient in chili peppers—can improve the anti-cancer activity of the commonly used chemotherapy drug cisplatin in patients with small cell lung cancer.
 
Dasgupta received the funding through the National Cancer Institute’s Academic Research Enhancement Award program. The program supports research projects in the biomedical and behavioral sciences that strengthen the research environment of the institution and expose students to research. Her co-investigator is Dr. Monica Valentovic, a professor in the same department.
 
“Small cell lung cancer is characterized by a high rate of growth, early metastasis and a dismal survival rate,” said Dasgupta. “Although chemotherapy works well initially in these patients, they often relapse quickly and become unresponsive to chemotherapy. Since the preliminary data in our laboratory shows that capsaicin manifests anti-cancer activity in this type of cancer, we are hopeful our studies under this new grant may lead to new treatments.”
 
She continued, “I am thrilled to receive this funding and I am grateful to a lot of people who have been instrumental in our success to this point. My collaborator Dr. Valentovic is a fabulous scientist to work with. I am also grateful to all the members of my lab for their hard work and dedication.”
 
Dasgupta also acknowledged the support of the chairman of her department, Dr. Gary Rankin, and acknowledged Dr. Marcia Harrison and the MU-ADVANCE program, which she says made it possible for undergraduate students to work in her lab. MU-ADVANCE is a National Science Foundation-funded program to help increase the number of female science and engineering faculty at the university.
 
Dasgupta says she believes her proposal was selected for funding at least in part because the grant program’s focus on student research made it a good match for her lab. Undergraduates working in her lab have a track record of receiving research grants, authoring publications and presenting their findings at international conferences.
 
Dr. John M. Maher, Marshall’s vice president for research, congratulated the researchers, saying, “NIH grants are extraordinarily competitive, and I applaud Drs. Dasgupta and Valentovic for having a successful application. They are doing vital research that may very well have a positive impact on human health in the not-so-distant future. In addition, the grant will allow them to continue to give students hands-on, meaningful research opportunities in the lab.”
 
In addition to receiving the new NIH funding, Dasgupta recently was notified that her grant from the Flight Attendant Medical Research Institute has been renewed for an additional two years. The renewal, which extends the original three-year award, makes the total grant worth nearly $550,000. That grant is funding Dasgupta’s study of how nicotine, the active component in cigarette smoke, facilitates the progression of lung cancer. Valentovic is also the co-investigator on that award. 

###

Drs. Claudio and Niles co-edit and publish an ebook on nutrition and cancer featuring BMS professors and students

Cover of "Nutrition and Cancer: From Epidemiology to Biology"Pier Paolo Claudio, M.D./Ph.D., and Richard M. Niles, Ph.D., of the Biomedical Sciences Graduate Program have co-edited and written articles in an ebook entitled “Nutrition and Cancer: From Epidemiology to Biology.” This ebook is one of the latest efforts of cancer researchers at the Marshall University Nutrition and Cancer Center, where the role of nutrition in cancer is actively and successfully investigated. The ebook contains a collection of scientific articles, written by researchers and students in the Marshall University Biomedical Sciences Graduate Program.  

The purpose of this publication is to educate and inform the public regarding the latest knowledge on nutrition and cancer. It focuses on the role of various nutritional components in cancer prevention, as well their present and future use in cancer therapy. According to Dr. Pier Paolo Claudio, “This e-book will be of interest to researchers in the nutrition and cancer field, physicians in family and community medicine, internal medicine and oncology, as well as dieticians providing counseling to cancer patients and cancer survivors.”

Dr. Niles says that the best description of the importance of this book can be found within the foreword, written by Dr. Gary Meadows of Washington State University:

“While we as individuals cannot modify our genetic makeup and may have little control over the multitude of carcinogens in our environment, we have the power to make healthy diet-based choices that can significantly modify cancer risk and progression. The authors have structured this book not only to review the epidemiological studies that support the roles of selected nutrients/phytochemicals in cancer control, but also they review the cellular and molecular pathways involved in their action as well as the clinical data related to their efficacy in cancer treatment. Consequently, this book has wide appeal not only to researchers in the nutrition and cancer field, but also to oncology practitioners, dieticians, as well as cancer survivors, who are interested learning how healthy dietary choices can enhance their quality of life.” 

According to Dr. Niles, editing the book involved reviewing each chapter and making suggestions for improvement of the content handwriting. He also co-wrote a chapter with Dr. Rankin on resveratrol, found in high concentration in red wine, and its ability to inhibit the development or progression of certain types of cancer. Dr. Claudio co-wrote an article with Ph.D. candidate M. Allison Wolf on isothiocyanates, phytochemicals found in cruciferous vegetables, which his lab found to target carcinogenesis during tumor initiation, promotion, and progression.

The following authors and articles are found within the ebook:

Richard M. Niles, Ph.D. and Gary O. Rankin, Ph.D.
Resveratrol, A Phytoalexin with a Multitude of Anti-Cancer Activities

Jamie K. Lau, Kathleen C. Brown, Aaron M. Dom and Piyali Dasgupta, Ph.D.
Capsaicin: Potential Applications in Cancer Therapy

W. Elaine Hardman, Ph.D.
Omega-3 Fatty Acids as an Adjuvant to Cancer Therapy

Richard Egleton, Ph.D.
Green Tea Catechins and Cancer

Kinsley Kelley Kiningham, Ph.D., and Anne Silvis
Receptor Independent Effects of Retinoids

Vincent E. Sollars, Ph.D.
Epigenetics as a Mechanism for Dietary Fatty Acids to Affect Hematopoietic Stem/Progenitor Cells And Leukemia – Royal Jelly for the Blood

Monica Valentovic, Ph.D. and Nalini Santanam, Ph.D./M.P.H.
Nutrition, Oxidative Stress and Cancer

John Wilkinson IV, Ph.D.
Is there an Etiologic Role for Dietary Iron and Red Meat in Breast Cancer Development?

M. Allison Wolf and Pier Paolo Claudio, M.D./Ph.D.
Isothiocyanates Target Carcinogenesis During Tumor Initiation, Promotion and Progression

The ebook can be ordered directly online through the Bentham Science website at the following link: http://198.247.95.142/ebooks/9781608054473/index.htm

Marshall scientist awarded NIH grant for lung cancer research

The following story from the Marshall University Research Corporation highlights two researchers within the Biomedical Sciences Graduate Program: Piyali Dasgupta, Ph.D., and Monica Valentovic, Ph.D.


Piyali Dagupta, Ph.D., and Monica Valentovic, Ph.D.

 HUNTINGTON, W.Va. – A Marshall University faculty member has been awarded a three-year, $426,000 grant by the National Institutes of Health (NIH) to further her lung cancer research.

Dr. Piyali Dasgupta, associate professor in the Department of Pharmacology, Physiology and Toxicology in the university’s Joan C. Edwards School of Medicine, will use the grant to continue her work to determine if the nutritional agent capsaicin—the active ingredient in chili peppers—can improve the anti-cancer activity of the commonly used chemotherapy drug cisplatin in patients with small cell lung cancer.

Dasgupta received the funding through the National Cancer Institute’s Academic Research Enhancement Award program. The program supports research projects in the biomedical and behavioral sciences that strengthen the research environment of the institution and expose students to research. Her co-investigator is Dr. Monica Valentovic, a professor in the same department.

“Small cell lung cancer is characterized by a high rate of growth, early metastasis and a dismal survival rate,” said Dasgupta. “Although chemotherapy works well initially in these patients, they often relapse quickly and become unresponsive to chemotherapy. Since the preliminary data in our laboratory shows that capsaicin manifests anti-cancer activity in this type of cancer, we are hopeful our studies under this new grant may lead to new treatments.”

She continued, “I am thrilled to receive this funding and I am grateful to a lot of people who have been instrumental in our success to this point. My collaborator Dr. Valentovic is a fabulous scientist to work with. I am also grateful to all the members of my lab for their hard work and dedication.”

Dasgupta also acknowledged the support of the chairman of her department, Dr. Gary Rankin, and acknowledged Dr. Marcia Harrison and the MU-ADVANCE program, which she says made it possible for undergraduate students to work in her lab. MU-ADVANCE is a National Science Foundation-funded program to help increase the number of female science and engineering faculty at the university.

Dasgupta says she believes her proposal was selected for funding at least in part because the grant program’s focus on student research made it a good match for her lab. Undergraduates working in her lab have a track record of receiving research grants, authoring publications and presenting their findings at international conferences.

Dr. John M. Maher, Marshall’s vice president for research, congratulated the researchers, saying, “NIH grants are extraordinarily competitive, and I applaud Drs. Dasgupta and Valentovic for having a successful application. They are doing vital research that may very well have a positive impact on human health in the not-so-distant future. In addition, the grant will allow them to continue to give students hands-on, meaningful research opportunities in the lab.”

In addition to receiving the new NIH funding, Dasgupta recently was notified that her grant from the Flight Attendant Medical Research Institute has been renewed for an additional two years. The renewal, which extends the original three-year award, makes the total grant worth nearly $550,000. That grant is funding Dasgupta’s study of how nicotine, the active component in cigarette smoke, facilitates the progression of lung cancer. Valentovic is also the co-investigator on that award.


Contact:  Ginny Painter, Communications Director, Marshall University Research Corporation, 304.746.1964

Marshall professor to share kidney research in China

Gary O. Rankin, Ph.D.HUNTINGTON, W.Va. – A Marshall University professor will be in Beijing this week to present his research at BIT’s 5 World Cancer Congress and to meet with colleagues at a leading university.

Dr. Gary O. Rankin, professor and chairman of the Department of Pharmacology, Physiology and Toxicology at the university’s Joan C. Edwards School of Medicine, will be at the conference to give a talk about his work to study how a substance found naturally in red wine can reduce some of the harmful effects of a commonly used anti-cancer drug.

According to Rankin’s study conducted in cooperation with colleague Dr. Monica A. Valentovic, resveratrol, a natural component of red wine, grapes, blueberries and peanuts, can reduce toxicity to the kidney caused by the chemotherapy drug cisplatin. The work is funded by a grant from the National Institutes of Health.

“Dr. Valentovic and I are using a human kidney cell line to look into the protective effects of resveratrol,” said Rankin. “We have found that the compound’s powerful antioxidant properties may be important in helping to protect the kidney from cisplatin’s harmful effects.”

Also at the conference, Rankin will help lead a scientific session, “Cancer rehabilitation, nutrition and management of cancer related complications.”

Before the meeting in Beijing, Rankin has been invited to visit the School of Biosystems Engineering and Food Science at Zhejiang University in Hangzhou, China, to give a seminar about his work in the field of chemical-induced injury to the kidney. He will describe how an agricultural fungicide, dimetachlone, which was developed in Japan and manufactured in China, causes kidney damage. He also will be presenting some of the work he and Valentovic have done on the protective effects of resveratrol on cisplatin toxicity.

Rankin will be accompanied on the trip by Dr. Yi Charlie Chen, an associate professor of biology at Alderson-Broaddus College in Philippi.

Both Rankin and Chen are lead researchers in the West Virginia IDeA Network of Biomedical Research Excellence—a federally funded program to help build biomedical research expertise across the state. Rankin is the principal investigator of the project and Chen is on the steering committee.

For more information, contact Rankin at 304-696-7313 or rankin@marshall.edu.

### 

BMS Program celebrates Seventh Annual Biomedical Sciences Research Retreat

Students attending the research retreatOn August 19, the faculty, staff, and students of the Biomedical Sciences (BMS) Graduate Program gathered together for the Seventh Annual Biomedical Sciences Research Retreat. Held at the Ramada Limited in Huntington, the retreat served as an excellent opportunity to socialize in an informal setting over a tasty lunch, share research projects and advancements, welcome a guest alumni speaker, and present awards for outstanding service and research. Dr. Elsa Mangiarua organized the event, as she does every year. Thanks to her guidance the event, as always, went smoothly and was a great success.

The event began with a buffet lunch, followed by time to mingle and view research posters. After lunch, a lively discussion commenced as research students and faculty members discussed their research projects with each other. Although this is a small group that interacts frequently, events such as this still evoke quite a bit of exchange and interest.

George Kamphaus, Ph.D.The poster presentations were followed by a seminar delivered by Dr. George Kamphaus, a graduate of the Biomedical Sciences Ph.D. Program who completed a Post-Doc at Harvard. He delivered a seminar entitled “Fc-Fusion of Clotting Factor IX: Development of a Long-acting Clotting Factor.” Dr. Kamphaus is currently a Senior Scientist working for Syntonix Pharmaceuticals. There is currently only one drug on the market targeted to treated Hemophilia B, and his company is working diligently to change this fact. Currently, Hemophilia B patients must receive injections of this drug twice weekly to treat their disease. The drug that Syntonix is developing is a clotting factor that has a longer duration of action, enabling patients to instead receive weekly injections. According to Dr. Kamphaus, there are patients in India suffering from this condition who must currently travel more than 12 hours to receive their injections; a drug that can be injected once weekly will make a significant difference in the lives of such patients.

During his seminar, Dr. Kamphaus spoke highly of the BMS Ph.D. Program, expressing that it prepared him well for a career in the pharmaceutical industry. Unlike more established academic programs that may employ a silo structure, pharmaceutical companies are often smaller start-ups that require researchers to frequently interact. According to Dr. Kamphaus, the interdisciplinary nature of the BMS Program prepared him well for this. He also spoke fondly of the level of concern from BMS Program instructors: “They care about their students, and this really comes across. The individual attention to students is extraordinary, and much different than what you would find in other programs. I think this sets up BMS graduates well for success.”

After the seminar, a representative from each research cluster delivered a short presentation covering current cluster research. Ben Owen, a Ph.D. student in the Neuroscience and Developmental Biology Cluster, discussed his research on action potentials; Aileen Marcelo, a Ph.D. Candidate in the Cardiovascular Disease, Obesity, and Diabetes Cluster, spoke of her work focusing on VEGF; Johannes Fahrmann, a Ph.D. Student in the Cancer Biology Cluster, discussed the effects of omega-3 fatty acids on downregulating NFkB within early-stage chronic lymphocytic leukemia; Dr. Gary Rankin of the Toxicology and Environmental Health Sciences Cluster updated the group on his work on genetic polymorphisms and unexpected methodone mortality; and Dr. Wei-ping Zeng of the Infectious and Immunological Diseases Cluster elaborated on his work with CD4 T cell differentiation.

Paula KounsThe cluster updates were followed by the presentation of awards for the 2010-2011 school year. Miranda Carper, President of the BMS GSO, presented the faculty awards. Awards were given to Dr. Travis Salisbury for Faculty Appreciation and Paula Kouns for Staff Appreciation. Dr. Salisbury was lauded for his accessibility to students. A student who nominated Dr. Salisbury remarked, “I appreciate the fact that he talks to me like an equal or a colleague.” In praise of Paula Kouns, another student stated: “Outside of being a genuinely nice and caring person, Paula goes above and beyond as our department secretary.”

 

Dr. Richard Niles presented the graduate student awards. The following students received awards: 

Sunil Kakarla, Ph.D. candidateBest Research Performance (Plaque and a paid trip to a national meeting up to $2,000): Sunil Kakarla

 

 

 

 

Anne Silvis, Ph.D. candidateBest Overall Performance as a Graduate Student (Plaque and a paid trip to an international meeting, up to $3,500): Anne Silvis

 

 

 

 

Highest GPA for a First Year Medical Sciences student (Plaque): Ross DeChant, Brittany Wall

Highest GPA for a First Year Research student (Plaque): Steven Rogers

Lotspeich Award ($1,000): Jesse Thornton

Best Creative Title for the Inaugural Issue of the BMS Magazine ($100): Miranda Carper

Thank you to our participants, speakers and award-winners. Also, a big thank you goes out to Dr. Mangiarua for doing such a great job in organizing the event! We look forward to seeing everyone at the gathering again next year.

Biomedical symposium begins at Marshall University

More than 150 people traveled to Marshall University Thursday to take part in the statewide Biomedical Research Symposium.

HUNTINGTON  Undergraduate students from Marshall and West Virginia University participated in a Biomedical Research Symposium Thursday.

A $16 million grant from the National Institutes of Health was awarded to the Marshall and West Virginia University researchers for the program.

Officials with the program said the program advances the students by interaction with others in the field. “It gives them a chance to interact with faculty and students who help shape their career as they go forward in the health sciences,” said organizer Dr. Gary Rankin.

Students spent Thursday evening in a poster session.

The original story can be read on the WOWK website: http://wowktv.com/story.cfm?func=viewstory&storyid=104268

Marshall receives 17.8-million-dollar NIH grant for research

Gary O. Rankin, Ph.D.Congratulations to Gary O. Rankin, Ph.D. and his WV-INBRE team for receiving the National Institutes of Health (NIH) competitive renewal grant of 17.8 million dollars! The grant will be for five years and will help continue a multidisciplinary research network with a scientific focus that will build and strengthen the lead and partner institutions (primarily undergraduate institutions) across West Virginia. “(This money) establishes research in colleges and universities around this state where research was never happening,” Dr. Rankin said. “It will lead to more dollars going to these universities, which will create new jobs.”

The WV-INBRE phase I was of great assistance to these WV institutions and the biomedical research infrastructure and network as a whole. Institutions have been able to purchase much needed research equipment, to be more competitive for funding, and to initiate more research projects. Additionally, when asked if he thought phase one of WV-INBRE was successful, Dr. Rankin noted “I think we have made quite a bit of progress. We have seen a cultural change; the value of research has been recognized. There is a greater appreciation for research as part of faculty career development and it is included when evaluating faculty for promotion and tenure.” With the newly awarded NIH funds for WV-INBRE phase II, these experiences will continue and enhance the science and technology knowledge of the state’s workforce.

Another benefit of WV-INBRE is the highly successful summer research experience that takes place at the lead institution, Marshall University, and the partner lead institution, West Virginia University. This nine-week summer research experience is designed to provide research opportunities for undergraduate students and help serve as a pipeline for undergraduate students to continue health-related research careers.

Ten interns are currently conducting research with their mentors at Marshall University and nineteen are participating in the WV-INBRE program at West Virginia University. At Marshall University,
Dr. Elsa Mangiarua coordinates a schedule for the students to augment their research experience. The students attend workshops concerning: biosafety, chemical safety, animal care, radiation safety, biomedical career opportunities, scientific communication, and graduate school. At the end of the experience the interns will present their research findings at a research symposium, to be held at Marshall and WVU on alternate years.

Below is a list of Marshall’s WV-INBRE participants and their laboratories. To learn more about the ongoing research in these labs, please click the links provided on Marshall’s Biomedical Sciences website faculty directory.

Don Bertolotti from WV State University – Dr. Larry Grover
Amanda Cochran from Bluefield State University – Dr. Pier Paolo Claudio
Elisa Evans from University of Charleston – Dr. Richard M. Niles
Kayla Fazio from Bluefield State University – Dr. Elaine Hardman
Brittany Greene from University of Charleston – Dr. Gary Rankin
Amelia Lloyd from University of Charleston – Dr. Hongwei Yu
Sumanth Manohar from WV State University – Dr. Maiyon Park
Kayanna Sayre from University of Charleston – Dr. Eric Blough
Donald Weller from University of Charleston – Dr. Piyali Dasgupta
Andrew White from University of Charleston – Dr. Philippe Georgel

Mike Brown and Lauren Richards Waugh receive Carl Smith Finalist Award

Congratulations to Mike Brown and Lauren Richards Waugh for receiving the Carl Smith Finalist Award!

The Carl Smith Award is given by the Mechanisms Specialty Section of the Society of Toxicology. This is a national competition and the finalists must submit a manuscript that is judged by a panel of academic, government and industrial toxicologists. The awards were presented at the Society of Toxicology meeting in Baltimore, MD by Dr. Gary Rankin, President of the Mechanisms Specialty Section.

Gary O. Rankin, Ph.D. and Mike BrownGary O. Rankin and Lauren Richards Waugh